• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtech stores we missed this week: March 10, 2017

March 10, 2017 By Danielle Kirsh

missedmedtechMD
[Image from unsplash.com]
The FDA and Health Canada cleared a couple medical devices while other companies touted their device studies. Here are medtech stories we missed this week but were still worth mentioning.

1. FDA clears Medela’s neonatal enteral feeding device

Medela has received 510(k) clearance from the FDA to market its ENFit Low Dose Tip eternal syringes, according to a March 9 press release. The syringes can help deliver accurate doses and reduce misconnection risks. The new syringes add to Medela’s NICU-specific enteral feeding system products that includes syringes, syringe pumps, warmers, feeding tubes and extension sets. The ENFit Low Dose Tip Syringe was also created to improve oral medication accuracy for small volume delivery in neonatal intensive care units.

2. PAVmed closes additional financing

PAVmed announced the closing of $1 million in additional financing in a March 9 press release. The gross proceeds of PAVmed’s private placement totaled $2.5 million after the closing. The private placement had shares from Series A Convertible Preferred Stock and Series A Warrants. The closing was first announcing in February.

3. InVivo Therapeutics enrolls 12th patient into Inspire study

InVivo Therapeutics announced that a new patient has enrolled in its study of probable benefit of the neuro-spinal scaffold for safety and neurologic recovery in subjects with complete thoracic AIS, according to a March 9 press release. The study, called Inspire for short, is being performed at the Keck Hospital of the University of Southern California. The study’s main researcher, Patrick Hsleh, was able to implant the neuro-spinal scaffold about 82 hours after the injury occurred.

Get the full story on our sister site, MassDevice.

Filed Under: Business/Financial News, Clinical Trials, Food & Drug Administration (FDA) Tagged With: Aboimed, Exact Imaging, Intellijoint Surgical, InVivo Therapeutics, Medela, medtech, Nexstim, PAVmed

IN CASE YOU MISSED IT

  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS